JOEL SHOUSE: Open Payments
NPI 1134762628 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 19 payments from 3 companies in 2025. Trend: 2023 $448 · 2024 $599 · 2025 $611
Food & beverage: $577Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $360 |
| GlaxoSmithKline, LLC. | 12 | $201 |
| Amgen Inc. | 2 | $49 |
Products named: TEZSPIRE, NUCALA, BREZTRI, TRELEGY ELLIPTA.
Industry payments across IN — which companies pay providers there.
